Differential complement activation by alloantibodies in sickle cell hyperhaemolysis syndrome may influence disease course.
Saved in:
| Title: | Differential complement activation by alloantibodies in sickle cell hyperhaemolysis syndrome may influence disease course. |
|---|---|
| Authors: | Thant MM; Department of Medicine, Division of Hematology-Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Hoxworth Blood Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Gollamudi J; Department of Medicine, Division of Hematology-Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Benoit SW; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Chonat S; Department of Pediatrics, Emory University and Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Cancelas JA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. |
| Source: | British journal of haematology [Br J Haematol] 2026 Jun; Vol. 208 (6), pp. 2311-2314. Date of Electronic Publication: 2026 Apr 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
